Home

Mangalam Drugs And Organics Ltd Quarterly Result

Image

Mangalam Drugs and Organics Ltd

NSE: MANGALAM

Net Profit - Last Quarter

₹ 2.69 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Mangalam Drugs and Organics Ltd for the Sep '24 is ₹ 80.08 crore as compare to the Jun '24 revenue of ₹ 76.56 crore. This represent the growth of 4.597707%.
  • The ebitda of Mangalam Drugs and Organics Ltd for the Sep '24 is ₹ 8.84 crore as compare to the Jun '24 ebitda of ₹ 8.21 crore. This represent the growth of 7.67357%.
  • The net profit of Mangalam Drugs and Organics Ltd for the Sep '24 is ₹ 2.69 crore as compare to the Jun '24 net profit of ₹ 2.68 crore. This represent the growth of 0.37313396%.

Results Analysis

Market Price of Mangalam Drugs and Organics Ltd

1M

1Y

3Y

5Y

Monitoring Mangalam Drugs and Organics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 2025106.8
14 Jan 2025104.05
13 Jan 2025101.95
10 Jan 2025111.65
09 Jan 2025115
08 Jan 2025112.3
07 Jan 2025114.5
06 Jan 2025111.3
03 Jan 2025118.35
02 Jan 2025120.65

Historical Revenue of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical EBITDA of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical Net Profit of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Mangalam Drugs and Organics Ltd News Hub

Mangalam Drugs and Organics reports standalone net profit of Rs 2.68 crore in the June 2024 quarter

Net profit of Mangalam Drugs and Organics reported to Rs 2.68 crore in the quarter ended June 2024 a

Read more

14 Aug 2024

Mangalam Drugs and Organics to declare Quarterly Result

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 13 Augus

Read more

10 Aug 2024

Mangalam Drugs and Organics AGM scheduled

Mangalam Drugs and Organics announced that the 51th Annual General Meeting (AGM) of the company will

Read more

25 Sep 2024

Mangalam Drugs and Organics to table results

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 14 Novem

Read more

08 Nov 2024

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Mangalam Drugs and Organics Ltd

What key financial metrics are included in Mangalam Drugs and Organics Ltd's quarterly results?

Key financial metrics in Mangalam Drugs and Organics Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Mangalam Drugs and Organics Ltd announce its quarterly results?

Mangalam Drugs and Organics Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Mangalam Drugs and Organics Ltd's quarterly performance impact its stock price?

Mangalam Drugs and Organics Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Mangalam Drugs and Organics Ltd's quarterly results on dividends?

The impact of Mangalam Drugs and Organics Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Mangalam Drugs and Organics Ltd's quarterly results?

Yes, Mangalam Drugs and Organics Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions